PI3K and cancer: lessons, challenges and opportunities
David A. Fruman, Christian Rommel · Nature Reviews Drug Discovery · 2014
Cited by 1,709 works. doi:10.1038/nrd4204
Authors
References
- Hallmarks of Cancer: The Next Generation
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
- High Frequency of Mutations of the PIK3CA Gene in Human Cancers
- A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region
- TOR Signaling in Growth and Metabolism
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- mTOR Signaling in Growth Control and Disease
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)